JW Pharmaceutical Announces US Patent for Gout Drug Epaminurad
한국면세뉴스 | 2025-12-03 12:55
JW Pharmaceutical announced on the 3rd that its gout treatment candidate, Epaminurad (URC102), has r
내용보러가기
내용보러가기







